ASCRS

Novel dexamethasone formulation shows efficacy and safety with once-daily use

September 01, 2020

A vehicle-controlled phase 2 study investigating once- and twice-daily administration of a novel, preservative-free topical formulation of dexamethasone as treatment for pain and inflammation after cataract surgery met its primary endpoints.

Image quality or depth of field — or both?

August 13, 2020

ICYMI: Alice Epitropoulos, MD, FACS, speaks on "Image quality or depth of field or both: Clinical outcomes from spherical aberration neutral monofocal toric IOL," during the 2020 ASCRS virtual meeting.

ASCRS 2020: Assessing aberration of monofocal toric IOL with enhanced optic recovery, alignment

June 17, 2020

Dee Stephenson, MD, ABO, discusses the highlights of her presentation "Early Clinical Assessment of Aberration Neutral One-Piece Monofocal Toric IOL with Enhanced Optic Recovery and Alignment ORA" during the 2020 ASCRS virtual meeting.

ASCRS 2020: Assessing aberration of monofocal toric IOL with enhanced optic recovery, alignment

June 17, 2020

ASCRS 2020: OSD improvement in eyes implanted with trabecular meshwork bypass stents

June 15, 2020

ASCRS 2020: Corneal CXL outcomes in children with progressive keratoconus

June 11, 2020

ASCRS 2020: Returning to baseline post-corneal collagen crosslinking for keratoconus

June 10, 2020

ASCRS 2020: Image quality, depth of field, or both?

June 09, 2020

ASCRS 2020: Evolution of an administration technique for DEXYCU

May 31, 2020

ASCRS 2020: Clinical trial results of KP1-121 0.25% for dry eye treatment

May 29, 2020